1.Gregg, NM. Congenital defects associated with maternal rubella. The Australian Hospital 1947; 14: 7–9.
2.Hinman, AR, et al. Economic analyses of rubella and rubella vaccines: a global review. Bulletin of the World Health Organization 2002; 80(4).
3.World Health Organization.Rubella vaccines: WHO position paper. Weekly Epidemiological Record 2011; 86: 301–316.
4.Anderson, RM, May, RM. Vaccination and herd immunity to infectious diseases. Nature 1985; 318: 323–329.
5.Anderson, RM, May, RM. Vaccination against rubella and measles: qualitative investigations of different policies. Journal of Hygiene (Cambridge) 1983; 90: 259–325.
6.Edmunds, WJ, et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiology and Infection 2000; 125: 635–650.
7.Gay, N. Modeling measles, mumps, and rubella: Implications for the design of vaccination programs. Fifth International Conference on the Prevention of Infection 1998; 19: 570–573.
8.van der Heilden, OG, et al. A model-based evaluation of the national immunization programme against rubella infection and congenital rubella syndrome in the Netherlands. Epidemiology and Infection 1998; 121: 653–671.
9.Bjørnstad, ON, Finkenstadt, B, Grenfell, BT. Endemic and epidemic dynamics of measles: Estimating epidemiological scaling with a time series SIR model. Ecological Monographs 2002; 72: 169–184.
10.Keeling, MJ, Rohani, P, Grenfell, BT. Seasonally forced disease dynamics explored as switching between attractors. Physica D 2001; 148: 317–335.
11.Bauch, CT, Earn, DJD. Transients and attractors in epidemics. Proceedings of the Royal Society of London, Series B 2003; 270: 1573–1578.
12.Knox, EG. Strategy for rubella vaccination. International Journal of Epidemiology 1980; 9: 13–23.
13.World Health Organization.Rubella vaccine: WHO position paper. Weekly Epidemiological Record 2000; 75: 161–172.
14.World Health Organization.Meeting of the Strategic Advisory Group of Experts on Immunization, April 2011 – conclusions and recommendations. Weekly Epidemiological Record 2011; 86: 205–220.
15.Vynnycky, E, Gay, NJ, Cutts, FT. The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome. Vaccine 2003; 21: 2708–2719.
16.World Health Organization.Global reductions in measles mortality 2000–2008 and the risk of measles resurgence. Weekly Epidemiological Record 2009; 49: 505–516.
17.Cutts, FT, Vynnycky, E. Modelling the incidence of congenital rubella syndrome in developing countries. International Journal of Epidemiology 1999; 28: 1176–1184.
18.Cutts, FT, et al. Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiology and Infection 2000; 124: 467–479.
19.Farrington, CP, Kanaan, MN, Gay, NJ. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Applied Statistics 2001; 50: 251–292.
20.Rios-Doria, D, et al. Spatial and temporal dynamics of rubella in Peru, 1997–2006: geographic patterns, age at infection and estimation of transmissibility. In Chowell, EA, ed. Mathematical and Statistical Estimation Approaches in Epidemiology. The Netherlands: Springer, 2009.
21.Metcalf, CJE, et al. The epidemiology of rubella in Mexico: seasonality, stochasticity and regional variation. Epidemiology and Infection 2011; 139: 1029–1038.
22.Metcalf, CJE, et al. Rubella meta-population dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru. Journal of the Royal Society Interface 2011; 8: 369–376.
23.Ferrari, MJ, et al. The dynamics of measles in sub-Saharan Africa. Nature 2008; 451: 679–684.
24.Ferrari, MJ, et al. Episodic outbreaks bias estimates of age specific force of infection: a corrected method using measles in Niamey, Niger as an example. Epidemiology and Infection 2010; 138: 108–116.
25.Klepac, P, Caswell, H. The stage-structured epidemic: linking disease and demography with a multi-state matrix approach. Theoretical Ecology 2010; 4: 301–319.
26.Klepac, P, et al. Stage structured transmission of phocine distemper virus in the Dutch 2002 outbreak. Proceedings of the Royal Society, Series B 2009; 276: 2469–2476
27.Metcalf, CJE, et al. Structured models of infectious disease: inference with discrete data. Theoretical Population Biology (in press).
28.Schenzle, D. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. IMA Journal of Mathematics Applied in Medicine and Biology 1984; 1: 161–191.
29.Finkenstadt, B, Grenfell, BT. Time series modelling of childhood diseases: a dynamical systems approach. Journal of the Royal Statistical Society, Series C 2000; 49: 187–205.
30.Glass, K, Xia, Y, Grenfell, BT. Interpreting time-series analyses for continuous-time biological models-measles as a case study. Journal of Theoretical Biology 2003; 223: 19–25.
31.Lessler, J, et al. Maintaining high rates of measles immunization in Africa. Epidemiology and Infection 2010; 139; 1039–1049.
32.Boulianne, N, et al. Measles, mumps, and rubella antibodies in children 5–6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 1995; 13: 1611–1616.
33.Grenfell, BT, Anderson, RM. The estimation of age-related rates of infection from case notifications and serological data. Journal of Hygiene (Cambridge) 1985; 95: 419–436.
34.Mclean, AR, Anderson, RM. Measles in developing countries part II: the predicted impact of mass vaccination. Epidemiology and Infection 1988; 100: 419–442.
35.Edmunds, WJ, et al. Modelling rubella in Europe. Epidemiology and Infection 2000;125: 617–634.
36.Earn, DJD, et al. A simple model for complex dynamical transitions in epidemics. Nature 2000; 287: 667–670.
37.Clarke, M, et al. Epidemiological studies of rubella virus in a tropical African community. Bulletin of the World Health Organization 1980; 58: 931–935.
38.Lessler, J, et al. Measuring the performance of vaccination programs using cross-sectional surveys. PLoS Medicine 2011; 8: e1001110.